Hims & Hers Appoints Tenured Pharmaceutical, Regulatory, and Quality Experts to Key Leadership Positions
Hims & Hers Health Options Spot-On: On November 18th, 120.53K Contracts Were Traded, With 590.92K Open Interest
HIMS Soars 12% on Ex-FDA Deputy Joining Board
Unpacking the Latest Options Trading Trends in Hims & Hers Health
Hims & Hers Health, Inc.'s (NYSE:HIMS) Stock Has Been Sliding But Fundamentals Look Strong: Is The Market Wrong?
Express News | Hims & Hers Health Shares up 2.7% After Appointing Former FDA Official to Board
![[undefined]](https://static.moomoo.com/nnq/emoji/static/image/default/default-black.png?imageMogr2/thumbnail/36x36 "undefined"){kind=small}
